Indoleamine-2,3-dioxygenase (IDO) metabolic activity is detrimental for cervical cancer patient survival

D.M. Ferns, I.P. Kema, M.R. Buist, H.W. Nijman, G.G. Kenter, E.S. Jordanova

Research output: Contribution to journal › Article › Academic › peer-review

Cite this

@article{e93df455855e440f9d7c100efe0bc40d,

title = "Indoleamine-2,3-dioxygenase (IDO) metabolic activity is detrimental for cervical cancer patient survival",

author = "D.M. Ferns and I.P. Kema and M.R. Buist and H.W. Nijman and G.G. Kenter and E.S. Jordanova",

year = "2015",

doi = "10.4161/2162402X.2014.981457",

language = "Undefined/Unknown",

volume = "4",

journal = "OncoImmunology",

issn = "2162-4011",

publisher = "Landes Bioscience",

number = "2",

}

TY - JOUR

T1 - Indoleamine-2,3-dioxygenase (IDO) metabolic activity is detrimental for cervical cancer patient survival

AU - Ferns, D.M.

AU - Kema, I.P.

AU - Buist, M.R.

AU - Nijman, H.W.

AU - Kenter, G.G.

AU - Jordanova, E.S.

PY - 2015

Y1 - 2015

U2 - 10.4161/2162402X.2014.981457

DO - 10.4161/2162402X.2014.981457

M3 - Article

C2 - 25949879

VL - 4

JO - OncoImmunology

JF - OncoImmunology

SN - 2162-4011

IS - 2

M1 - e981457

ER -